RESULTS	Median time to normalization was 91 days for risedronate-treated patients and > 360 days for etidronate-treated patients ( P < 0.001 ) ; relapse rates were 3 % in the risedronate group and 15 % in the etidronate group ( P < 0.05 ) .\